BCEL RSI Chart
Last 30 days
12.5%
Last 90 days
-71.0%
Trailing 12 Months
-91.8%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 11, 2024 | orwin john a | bought | 0.01 | 0.01 | 1.00 | president & ceo |
Apr 01, 2024 | serafini tito | sold | -1,455 | 0.07 | -20,788 | - |
Oct 19, 2023 | baker bros. advisors lp | sold | -110,582 | 0.4025 | -274,739 | - |
Sep 01, 2023 | serafini tito | sold | -3,144 | 0.3746 | -8,393 | - |
Sep 01, 2023 | orwin john a | sold | -8,597 | 0.3746 | -22,951 | president & ceo |
Sep 01, 2023 | courtney phillips | sold | -2,645 | 0.3746 | -7,061 | general counsel & secretary |
Aug 02, 2023 | gould stephen e | sold | -3,881 | 0.9522 | -4,076 | chief scientific officer |
Aug 02, 2023 | courtney phillips | sold | -3,881 | 0.9522 | -4,076 | general counsel & secretary |
Aug 02, 2023 | cross herb | sold | -5,224 | 0.9522 | -5,487 | chief financial officer |
Aug 02, 2023 | serafini tito | sold | -5,224 | 0.9522 | -5,487 | chief strategy officer |
Which funds bought or sold BCEL recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -1,505 | - | -% |
May 15, 2024 | STATE STREET CORP | sold off | -100 | -11,790 | - | -% |
May 15, 2024 | MORGAN STANLEY | sold off | -100 | -601 | - | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | sold off | -100 | -76.00 | - | -% |
May 15, 2024 | BARCLAYS PLC | sold off | -100 | -6,000 | - | -% |
May 15, 2024 | Federation des caisses Desjardins du Quebec | new | - | 76.00 | 76.00 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | sold off | -100 | -15.00 | - | -% |
May 15, 2024 | Boxer Capital, LLC | sold off | -100 | -290,708 | - | -% |
May 15, 2024 | Redmile Group, LLC | sold off | -100 | -58,430 | - | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | sold off | -100 | -12,071 | - | -% |
Unveiling Atreca Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Atreca Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Atreca Inc News
Balance Sheet | ||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2018Q4 |
Assets | -77.1% | 26.00 | 115 | 134 | 155 | 172 | 191 | 214 | 200 | 220 | 241 | 262 | 272 | 275 | 165 | 179 | 196 | 213 | 227 | 122 |
Current Assets | -41.2% | 25.00 | 42.00 | 60.00 | 78.00 | 93.00 | 110 | 123 | 122 | 162 | 193 | 225 | 249 | 264 | 149 | 154 | 176 | 206 | 222 | 117 |
Cash Equivalents | -51.3% | 13.00 | 28.00 | 39.00 | 31.00 | 22.00 | 28.00 | 50.00 | 96.00 | 115 | 95.00 | 91.00 | 62.00 | 135 | 102 | 93.00 | 159 | 167 | 156 | 115 |
Net PPE | -95.5% | 2.00 | 35.00 | 37.00 | 38.00 | 40.00 | 41.00 | 42.00 | 43.00 | 44.00 | 45.00 | 34.00 | 20.00 | 8.00 | 8.00 | 7.00 | 6.00 | 5.00 | 4.00 | 4.00 |
Liabilities | -77.9% | 16.00 | 70.00 | 73.00 | 77.00 | 76.00 | 76.00 | 76.00 | 45.00 | 45.00 | 42.00 | 40.00 | 30.00 | 14.00 | 10.00 | 9.00 | 9.00 | 8.00 | 8.00 | 5.00 |
Current Liabilities | 29.8% | 16.00 | 12.00 | 14.00 | 16.00 | 15.00 | 13.00 | 13.00 | 17.00 | 16.00 | 14.00 | 19.00 | 17.00 | 9.00 | 7.00 | 7.00 | 8.00 | 8.00 | 8.00 | 5.00 |
Shareholder's Equity | -75.9% | 11.00 | 45.00 | 61.00 | 78.00 | 96.00 | 115 | 138 | 155 | 175 | 199 | 221 | 242 | 261 | 154 | 170 | 187 | 205 | 219 | - |
Retained Earnings | -7.3% | -533 | -497 | -477 | -456 | -435 | -412 | -384 | -359 | -330 | -302 | -276 | -250 | -227 | -204 | -184 | -164 | -143 | -128 | -96.62 |
Additional Paid-In Capital | 0.4% | 544 | 542 | 539 | 536 | 532 | 528 | 523 | 515 | 506 | 501 | 498 | 492 | 489 | 358 | 354 | 351 | 349 | 347 | 4.00 |
Shares Outstanding | 0.6% | 39.00 | 39.00 | 39.00 | 39.00 | 39.00 | 39.00 | 38.00 | 37.00 | 37.00 | 37.00 | 37.00 | 32.00 | 30.00 | 28.00 | 28.00 | 16.00 | 12.00 | 5.00 | 2.00 |
Float | - | - | - | - | - | - | 49.00 | - | - | - | 198 | - | - | - | 305 | - | - | - | 211 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 4.3% | -17,216 | -17,984 | -14,444 | -15,433 | -16,360 | -23,377 | -25,551 | -16,106 | -16,053 | -11,063 | -17,698 | -18,097 | -14,979 | -15,681 | -17,914 | -16,219 | -15,591 | -13,751 | -12,977 | - | - |
Share Based Compensation | -19.8% | 2,297 | 2,863 | 3,223 | 3,183 | 3,884 | 5,488 | 4,336 | 4,741 | 3,853 | 3,882 | 4,400 | 3,123 | 3,487 | 3,384 | 2,482 | 2,043 | 1,878 | 1,359 | 776 | - | - |
Cashflow From Investing | -51.6% | 2,991 | 6,185 | 23,000 | 25,349 | 10,329 | 1,259 | -24,389 | -6,710 | 35,298 | 14,741 | 45,908 | -54,625 | -78,785 | 23,215 | -48,800 | 7,986 | 29,467 | 9,071 | -74,428 | - | - |
Cashflow From Financing | 800.0% | 9.00 | 1.00 | 109 | - | 145 | -9.00 | 3,767 | 4,373 | 341 | 19.00 | 713 | 439 | 126,963 | 526 | 943 | 43.00 | -2,133 | 133,320 | -56.00 | - | - |
Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Expenses | ||||
Research and development | $ 10,407 | $ 16,045 | $ 36,774 | $ 53,062 |
General and administrative | 5,386 | 7,247 | 20,300 | 23,930 |
Restructuring and impairment charges | 20,856 | 20,856 | ||
Total expenses | 36,649 | 23,292 | 77,930 | 76,992 |
Interest and other income (expense) | ||||
Other income | 80 | 243 | 750 | |
Interest income | 354 | 233 | 1,276 | 430 |
Net other income (expense) | 434 | 233 | 1,519 | 1,180 |
Loss before income tax expense | (36,215) | (23,059) | (76,411) | (75,812) |
Net loss | $ (36,215) | $ (23,059) | $ (76,411) | $ (75,812) |
Net loss per share, basic (in dollars per share) | $ (0.92) | $ (0.60) | $ (1.95) | $ (1.97) |
Net loss per share, diluted (in dollars per share) | $ (0.92) | $ (0.60) | $ (1.95) | $ (1.97) |
Weighted-average shares used in computing net loss per share, basic (in shares) | 39,354,502 | 38,720,575 | 39,202,045 | 38,434,327 |
Weighted-average shares used in computing net loss per share, diluted (in shares) | 39,354,502 | 38,720,575 | 39,202,045 | 38,434,327 |
Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current Assets | ||
Cash and cash equivalents | $ 13,470 | $ 30,819 |
Investments | 7,918 | 39,676 |
Prepaid expenses and other current assets | 3,305 | 7,531 |
Total current assets | 24,693 | 78,026 |
Property and equipment, net | 1,614 | 37,972 |
Operating lease right-of-use assets | 36,056 | |
Deposits and other | 35 | 2,976 |
Total assets | 26,342 | 155,030 |
Current Liabilities | ||
Accounts payable | 4,062 | 1,741 |
Accrued expenses | 9,292 | 9,681 |
Operating lease liabilities, current portion | 1,281 | 3,544 |
Other current liabilities | 948 | 1,327 |
Total current liabilities | 15,583 | 16,293 |
Operating lease liabilities, net of current portion | 60,331 | |
Total liabilities | 15,583 | 76,624 |
Commitment and contingencies (Note 9) | ||
Stockholders' equity | ||
Additional paid-in capital | 544,094 | 535,592 |
Accumulated other comprehensive loss | (4) | (266) |
Accumulated deficit | (533,335) | (456,924) |
Total stockholders' equity | 10,759 | 78,406 |
Total liabilities and stockholders' equity | 26,342 | 155,030 |
Class A common stock | ||
Stockholders' equity | ||
Common stock | 3 | 3 |
Class B common stock | ||
Stockholders' equity | ||
Common stock | $ 1 | $ 1 |